Clinical Features, Dermoscopic Patterns and Histological Diagnostic Model for Melanocytic Tumors of Uncertain Malignant Potential (MELTUMP) by Teresa Pusiol et al.
185ACTA DERMATOVENEROLOGICA CROATICA
Clinical Features, Dermoscopic Patterns, and  
Histological Diagnostic Model for Melanocytic Tumors 
of Uncertain Malignant Potential (MELTUMP)
Teresa Pusiol1, Francesco Piscioli1, Luigi Speziali2, Maria Grazia Zorzi1, 
Doriana Morichetti1, Luca Roncati1,3
1Provincial Health Care Services, Institute of Pathology, Santa Maria del Carmine Hos-
pital, Rovereto (TN), Italy; 2Provincial Health Care Services, Division of Dermatology, 
Santa Maria del Carmine Hospital, Rovereto (TN), Italy; 3Department of Diagnostic and 
Clinical Medicine and of Public Health, Section of Pathology, University of Modena 
and Reggio Emilia, Modena (MO), Italy
Corresponding author:
Luca Roncati MD, PhD 
Department of Diagnostic and Clinical Medicine  
and of Public Health
Section of Pathology





Received: August 18, 2014
Accepted: August 20, 2015
Acta Dermatovenerol Croat  2015;23(3):185-194            CLINICAL ARTICLE
ABSTRACT Cutaneous melanocytic lesions with atypical histological 
features can be difficult to categorize as benign or malignant. In the 
diagnosis of melanocytic lesions, the melanocytic tumor of uncer-
tain malignant potential (MELTUMP) category has been widely used. 
Although one may favor a benign or malignant interpretation, a de-
finitive diagnosis is not always possible, and long term clinical follow-
up remains the only true evidence of biological behavior. We report 
14 cases of MELTUMP with expert second opinion. Clinical pictures 
were available in 8 cases; dermoscopy was available in 5 cases. Accu-
rate guidelines are delineated in the formulation of the diagnosis. We 
think that the histological diagnosis should be accompanied by a note 
in which the pathologist describes the histological pattern that has 
generated diagnostic uncertainty. Since the MELTUMP term does not 
exclude the malignant nature of the lesion, all microstaging attributes 
for melanoma should be added. Moreover, superficial atypical melano-
cytic proliferation of uncertain significance (SAMPUS) and MELTUMP 
categories should be included in the WHO classification of melanocytic 
tumors of the skin. The role of sentinel lymph node biopsy in MELTUMP 
has not yet been established. Recent studies have looked at concur-
rent tumor deposits in lymph nodes of MELTUMP, mostly of atypical 
Spitzoid lesions, and shown that these lesions rarely progress to overt 
malignancy. In our study, sentinel node metastasis was found in only 
one case. The follow-up period of this case and of the others has shown 
that the clinical outcome of MELTUMP tends to be favorable.
KEY WORDS: melanocytic tumors of uncertain malignant potential 
(MELTUMP); superficial atypical melanocytic proliferation of uncertain 
significance (SAMPUS); clinical management; dermoscopy; histology; 
second opinion; sentinel lymph node (SLN)
INTRODUCTION
Melanocytic tumors of uncertain malignant po-
tential (MELTUMP) represent a highly select subset 
of melanocytic lesions that is difficult to classify cor-
rectly as benign or malignant, reflecting an inherent 
biologic problem. They probably represent a spec-
trum or group of one or more low-grade melanocytic 
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tumors with potential for lymph node involvement 
and, rarely, for distant metastasis (1-3). In the diag-
nosis of these lesions the second opinion is manda-
tory (2). We report the histological diagnostic model, 
according to expert second opinion, of 14 cases of 
MELTUMP, 8 of which are accompanied by clinical im-
ages and 5 by both clinical and dermoscopic pictures. 
All cases were reviewed by an expert consultant. 
PATIENTS AND METHODS
Fourteen cases of MELTUMP were retrieved from 
the files of the Institute of Pathology, Rovereto Hos-
pital. Inclusion criteria were as follows: a) histological 
cases of melanocytic tumors with uncertain classifi-
cation (benignant vs. malignant) sent out for expert 
second opinion; b) samples completely excised (no 
shave, no punch, no partial biopsies); and c) follow-
up period >3 years. Lesions were evaluated for tumor 
thickness, tumor infiltrating lymphocytes (TIL), and 
dermal mitotic figures/mm2 (mitogenicity). Eight cas-
es were accompanied by clinical images and five of 
them by both clinical and dermoscopic pictures.
RESULTS
The results are shown in Table 1. The median age 
of the 14 patients was 34.8 years (range: 14 to 68 
Figure 1. A (macroscopy): A pink papulo-nodular lesion with a smooth surface, focal pigmented areas on the top, and 
blurred margins. B and C (microscopy): Severely atypical combined melanocytic proliferation with Spitzoid features. 
While the lesion shows focally severe cytologic atypia, it is overall symmetrical with a plexiform/infiltrative architec-
ture at the base, so it was considered to have uncertain malignant potential [case 1].
Figure 2. A (macroscopy): A pigmented oval asymmetric lesion with sharp borders and a pink raised eccentric area. 
B and C (microscopy): Lentiginous compound dysplastic nevus with severe atypia of both the intraepidermal and 
intradermal components. Focal malignant change within the superficial component of this lesion cannot be entirely 
excluded and it is therefore best considered to have uncertain malignant potential [case 3].
Figure 3. A (macroscopy): An asymmetric pigmented le-
sion with a flat light brown component, a raised blue-
grayish area with smooth surface, and blurred margins. 
B (dermoscopy): The flat area has a regular reticular pat-
tern, while the raised area has a bluish homogeneous 
pattern with focal bluish globules at the inferior pole 
and irregular vessels at the superior pole. C and D (mi-
croscopy): Atypical epithelioid cell compound melano-
cytic proliferation, most consistent with epithelioid cell/
Schwannian transformation in a lentiginous compound 
nevus. The lesion is best regarded as having uncertain 
biological potential [case 4].
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years), there were 9 male and 5 female patients, the 
average tumor thickness was 2.5 mm, and the me-
dian number of dermal mitosis/mm2 was 1.3. Brisk 
tumor-infiltrating lymphocytes (TIL) were found in 5 
cases, non-brisk TIL in 1 case, and 8 cases showed no 
TIL. No patients presented with ulceration. Eight le-
sions were found on the trunk, while 4 lesions were 
located on the extremities and 2 lesions were de-
tected on the head. Clinical pictures were available 
in 8 cases (panel A in Figure 1, 2, 3, 4, 5, 6, 7; Figure 
8). In these cases the median diameter of the lesion 
was 9.25 mm (range: 6 to 15 mm). The clinical fea-
tures were suggestive of malignant melanoma in 6 of 
these 8 cases. Applying the ABCD rule, 4 lesions were 
Asymmetric, 3 lesions presented irregular Borders, 6 
lesions had an uneven Color, and 3 lesions showed a 
Dimension more than 6 mm. Dermoscopy was avail-
able in 5 cases, 4 of which with images (panel B in Fig-
ure 3, 5, 6, 7). All cases showed some features of ma-
lignancy: atypical vascular pattern (2 cases), atypical 
Figure 4. A (macroscopy): A polypoid reddish lesion with smooth surface and sharp borders. B and C (microscopy): 
Severely atypical compound Spitzoid melanocytic neoplasm. The lesion is dominated by a large expansive nodule 
devoid of maturation and containing numerous mitoses. Cytologically, the nodule is composed of cells with signifi-
cant atypia but without features of fully-evolved melanoma, and there is a small cell component with more nevoid 
features at the perimeter. Overall, the lesion must at least be considered to represent a melanocytic tumor of uncertain 
malignant potential [case 7].
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Figure 5. A (macroscopy): A slightly raised pigmented 
lesion with color variegation and sharp borders. B (der-
moscopy): A multicomponent global pattern, peripheral 
globules, focal irregular striae, irregular hyperpigmented 
structureless areas in the center of the lesion, and blue-
black blotch in close proximity of the striae. C and D 
(microscopy): Severely atypical compound melanocytic 
proliferation consistent with a melanocytic tumor of un-
certain malignant potential. Worrisome features include 
its breadth and focal asymmetry zones of junctional con-
fluence, occasional high-level pagetoid cells within the 
epidermis, and incomplete maturation by a focally co-
alescent and expansive dermal component involving en-
larged epithelioid cells with marked nuclear atypia [case 
12].
Figure 6. A (macroscopy): Asymmetric hypercromic flat 
lesion with irregular borders. B (dermoscopy): A multi-
component global pattern, irregular pigmented striae on 
about three-quarters of the lesion, irregular pseudopodia 
in the remaining part, and whitish-blue irregular areas in 
the middle. C and D (microscopy): Compound pigmented 
melanocytic proliferation with severe atipia. The lesion 
shows some overlap with an epithelioid variant of a pig-
mented spindle cell nevus of Reed. However, there is dis-
turbing cytological atypia, mitotic figures are easily found 
in the dermal component, and there is a focally brisk lym-
phoid infiltrate possibly representing an early inflamma-
tory phase of regression, as observed in borderline lesions 
of uncertain biological potential [case 13].
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classification of melanocytic tumors, atypical or am-
biguous lesions have been not considered (4). After 
the publication of the WHO histologic classification 
of melanocytic tumors, numerous reports described 
a subset of cases in which a specific and reproducible 
diagnosis is difficult or even impossible to establish 
(1,2,5). In the AFIP fascicle of the melanocytic tu-
mors of the skin (6), Elder and Murphy divided these 
cases into two categories: the Superficial Atypical 
Melanocytic Proliferation of Uncertain Significance 
(SAMPUS), a non-tumorigenic group of junctional 
melanocytic lesions and melanocytic proliferations 
that are confined to the epidermis and papillary 
dermis without evidence of mitotic activity; and the 
MELanocytic Tumors of Uncertain Malignant Poten-
tial (MELTUMP), a descriptive term for an ill-defined 
group of dermal melanocytic tumors that are often 
quite bulky and frequently exophytic, exhibiting one 
or several features indicative of possible malignancy 
but insufficient in number or degree to justify a diag-
nosis of malignancy. The MELTUMP category should 
include melanocytic proliferations that may gener-
ate uncertainty and which have been referred to in 
the past by various names: compound nevocellular 
nevi with dermal mitoses and atypia, Spitz nevi with 
atypical features (atypical Spitz tumors), pigmented 
spindle cell nevi with dermal atypia, dermal-based 
borderline melanocytic tumors, dysplastic nevi with 
dermal atypia, halo and inflamed nevi with atypia, 
desmoplastic nevi with unusual features, cellular 
blue nevi with atypia, some deep penetrating nevi, 
pigmented epithelioid melanocytomas, nevi lacking 
maturation, and any Spitz nevus in older individuals 
(3). MELTUMP is a provisional diagnosis; although a 
particular physician may favor a benign or malignant 
interpretation, a definitive diagnosis is not always 
Figure 7. A (macroscopy): A pigmented, slightly raised 
oval lesion with color variegation and blurred irregular 
borders. B (dermoscopy): A multicomponent global pat-
tern, irregular hyperpigmented structureless areas in the 
lower part and focal regression in the upper half, and fol-
licular structures reminiscent of comedo-like openings 
and milia-like cysts in the middle. C and D (microscopy): 
Severely atypical compound melanocytic proliferation 
with halo-like lymphoid response. While the melano-
cytic proliferation is diffusely and severely atypical, only 
one small region borders on melanoma in situ, and sev-
eral junctional nests at the perimeter appear nevoid. The 
lesion is best regarded as a melanocytic tumor of uncer-
tain malignant potential [case 14].
Figure 8. Macroscopic appearance of the raised nodular 
polypoid grayish lesion of the left scalp with a smooth 
surface, later diagnosed as MELTUMP [case 6].
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pigment network (3 cases), gray-blue areas (1 case), 
irregular diffuse pigmentation (blotches) (1 case), and 
regression pattern (1 case). All cases were reviewed 
by an expert dermatopathologist (panel B in Figure 
1, 2, 4; panel C in Figure 1, 2, 3, 4, 5, 6, 7; panel D in 
Figure 3, 5, 6, 7). The second opinion is reported in 
Table 1 as “assessment” and “comment/recommenda-
tion”. The TIL is reported in Table 1 as well. In all cases, 
vascular/lymphatic invasion and microscopic satel-
lites were not observed. Thirteen patients underwent 
widened excision: in only a single case was a residual 
tumor found. Biopsy of the sentinel lymph node (SLN) 
was performed in 6 patients, one of which resulted 
positive. A regional lymphadenectomy was done, but 
no additional metastases were found. All patients 
were free of disease after a follow-up period of >3 
years (range: 38 to 54 months).
DISCUSSION
The term “atypical” has been widely used for mela-
nocytic lesions in which a degree of atypia is evident, 
a source of some concern to the pathologist but in-
sufficient to merit a diagnosis of outright malignancy. 
In the World Health Organization (WHO) histological 
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While the lesion shows focally 
severe cytologic atypia it is 
overall symmetrical and shows 
a plexiform / infiltrative archi-
tecture at the base. Moreover, 
mitotic figures are infrequent. 
Spitzoid melanocytic prolifera-
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of a Spitz tumor, the patient’s 
age and the severe atypia are 
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as melanocytic tumors of un-
certain malignant potential 
(MELTUMP). Complete excision 
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certain malignant potential, 
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features with a superficial 
variant of a deep penetrating 
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biological potential. Moreover, 
the extent of cytologic atypia 
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tered in a deep penetrating ne-
vus; therefore, the lesion is best 
classified as having uncertain 
biological potential. Re-excision 
is recommended in a manner to 
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ing lesion. Although the nodule 
displays profound architectural 
atypia and variable cytologic 
dysplasia, mitotic figures are 
difficult to identify. Nonethe-
less, such lesions are best clas-
sified in the provisional cat-
egory of melanocytic tumor of 
uncertain malignant potential 
(MELTUMP). As such, complete 
excision is recommended in a 
manner to ensure against local 
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This is an extremely difficult 
lesion. The overall cytology is 
suggestive of origin in a Spitz 
nevus. The lesion is dominated 
by a large expansive nodule 
devoid of maturation and con-
taining numerous mitoses. Cy-
tologically, the nodule is com-
posed of cells with significant 
atypia but without features of 
fully-evolved melanoma, and 
there is a small cell component 
with more nevoid features at 
the perimeter. Overall, the le-
sion must be considered to 
represent at least a melanocytic 
tumor of uncertain malignant 
potential, with Spitzoid malig-
nant, invasive to a depth of ap-
proximately 2.5 mm, anatomic 
level IV not entirely excluded. 
In either case, it should be 
noted that such severely atypi-
cal Spitzoid tumors in children 
and young adults tend to have 
a more favorable prognosis 
that would be predicted for 
conventional melanoma, with 
long-term survival even in the 
presence of regional lymph 
node involvement. Such pa-
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Such lesions that do not fully 
qualify for a diagnosis of con-
ventional melanoma are best 
considered in the provisional 
category of melanocytic tumor 
of uncertain malignant poten-
tial (MELTUMP). Such lesions 
generally do not have the same 
prognostic implications of mel-
anoma, and even fully-evolved 
Spitzoid melanoma tends to 
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Although the lesion does 
not qualify for a diagnosis of 
melanoma, Spitzoid lesions in 
adults are notoriously difficult 
to classify. The lesion is best 
considered as having uncertain 
biologic potential. A complete 
excision to ensure against lo-
cal persistence / recurrence is 
advised.
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This unusual tumor, while dif-
fusely atypical arid mitotically 
active, is strikingly nevoid with 
respect to architecture, matura-
tion and pigment distribution. 
Some of the features are “Spit-
zoid”, including its relationship 
to the epidermis and perme-
ative and sclerosing deep der-
mal component. I would recom-
mend additional excision with a 
2-cm margin, careful screening, 
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This is an extremely interest-
ing and challenging lesion. 
Worrisome features include its 
breadth and focal asymmetry 
zones of junctional confluence 
and occasional high-Ievel pag-
etoid cells within the epidermis, 
and incomplete maturation by 
a focally coalescent and expan-
sive dermal component involv-
ing enlarged epithelioid cells 
with marked nuclear atypia. 
However, many of the junc-
tional and intradermal nests 
are more nevoid in architecture 
and cytology, mitotic figures 
or apoptotic cells are not ob-
served, and several regions 
within the dermis show fea-
tures reminiscent of combined 
nevus (dysplastic and deep 
penetrating types). Moreover, 
many of the dermal elements 
fail to express HMB-45. Over-
all, I do not believe that the 
lesion has sufficient criteria for 
a designation of conventional 
melanoma, and thus prefer the 
MELTUMP category (as further 
described in the AFIP Fascicle, 
Melanocytic Tumors of the Skin, 
Third Series). This is not a defini-
tive category, but rather a pro-
visional one that requires sub-
stantial further genomic and 
epigenomic study to determine 
true biological significance. In 
my experience, however, most 
lesions with such hybrid histo-
logic features do not behave as 
aggressively as melanoma, and 
complete excision is often cu-
rative. In addition to complete 
excision, careful screening and 
close interval follow-up are 
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possible at initial presentation, and long term (or per-
haps life-long) clinical follow-up remains the only true 
evidence of biological behavior. These lesions often 
require expert consultation and, frequently, prompt 
aggressive management such as would accompany 
a melanoma diagnosis (7,8). Since the diagnosis of 
MELTUMP is provisional, accurate guidelines should 
be delineated in the formulation of the diagnostic 
report. Elder and Xu believe that the final diagnosis 
of MELTUMP should be accompanied in the report 
by a note in which the pathologist describes the his-
tological findings that have generated diagnostic 
uncertainty (1). Since a MELTUMP category does not 
exclude the possibility of the malignant nature of the 
lesion, all microstaging attributes should be always 
reported. These parameters should be considered 
by a dermatologist in the management of the lesion 
and in the prognostic models. In our experience with 
“second opinions”, we believe that the histological 
report of MELTUMP should include the “assessment” 
and the “comment/recommendation” sections. In the 
“assessment”, the histological characteristics of the le-
sion should be accurately reported. In the “comment/
recommendation” section, the MELTUMP diagnosis 
should be accompanied by recommendations for the 
management of the lesion. There is little clinical data 
for MELTUMP: it may be associated with high rates of 
loco-regional involvement, including sentinel node 
metastasis. The rate of involvement reported varies 
from about 16% to 50% (9,10,11). In patients with 
MELTUMP who have undergone completion lymph-
adenectomy it is very unusual for the disease to re-
occur, while in adults with melanoma and a positive 
sentinel node about 1/6 or 1/7 have further nodes 
showing melanoma after completion lymphadenec-
tomy. Even patients with MELTUMP who had local or 
Pusiol et al. Acta Dermatovenerol Croat
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with an epithelioid variant of a 
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This is a challenging lesion. 
While the melanocytic prolif-
eration is diffusely and severely 
atypical, only one small region 
borders on melanoma in situ 
and several junctional nests at 
the perimeter appear nevoid. 
Moreover, in my experience, 
halo-like immune responses in 
overt melanomas are unusual. 
Nonetheless, the lesion is best 
regarded as a melanocytic tu-
mor of uncertain malignant 
potential (MELTUMP), with an 
unusual melanoma (level III, 0.5 
mm) difficult to fully exclude. 
Additional excision, careful 
screening, and close follow-up 
are recommended. Overall, I 




TIL: Tumor-infiltrating lymphocytes; FD: Free of Disease; SLNB: Sentinel Lymph Node Biopsy
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nodal recurrence did not usually develop significant 
systemic disease, although there was an occasional 
report of death (9,12,13). Luo and colleagues reported 
that the mortality for adult atypical Spitzoid tumors 
is less than 5%; thus, sentinel lymph node positivity, 
which is 30-50%, is poorly predictive of outcome. In 
cases with metastatic SLN there may be a temptation 
to revise the diagnosis to malignant melanoma (14). 
Therefore, in a situation where a “melanocytic tumor 
of uncertain malignant potential” is found to be as-
sociated with regional lymph node metastases, Elder 
and Xu use the definition of “metastatic melanocytic 
tumor of uncertain malignant potential”. The authors 
indicate that the biological potential of this meta-
static tumor remains uncertain (1). Abraham et al. 
believe that the role of SNL biopsy in MELTUMP has 
not yet been established (9,12). Recent studies have 
looked at concurrent tumor deposits in lymph nodes 
of MELTUMP, mostly of atypical Spitzoid neoplasms, 
and show that these lesions rarely progress to overt 
malignancy (7). Since SNL biopsy is not currently the 
standard of care in these lesions and can potentially 
cause morbidity, especially with completion lymph-
adenectomy, the lymphatic invasion identified by im-
munohistochemical staining could provide a surro-
gate marker for sentinel lymph node positivity (7). In 
our study, only one case of SNL metastasis was found, 
but the patient was free of disease after 40 months 
of follow-up. In the documentation on these lesions, 
most MELTUMPs had been examined in consultation 
so the clinical features were not accurately described. 
Clinical pictures were available in 8 cases. The clinical 
features were suggestive of malignant melanoma in 
6 of these 8 cases. Applying the ABCD rule, 4 lesions 
were considered asymmetric, 3 lesions presented with 
irregular borders, 6 lesions had an uneven color, and 
3 lesions measured >6 mm. Dermoscopy has been in-
creasingly regarded as a valuable aid in diagnosis of 
early melanoma. Of particular value in the diagnosis 
of melanoma is the presence of an irregular pigment 
network (uneven thickness of the lines, presence of 
broad lines at the periphery of the lesion), of black or 
brown dots irregularly distributed within the lesion, 
irregular lines at the lesion’s periphery that are not 
clearly combined with the pigment network (streaks), 
a blue-whitish veil corresponding to infiltrates of 
melanophages below a thick epidermis with hyper-
granulosis, an atypical vascular pattern, and regres-
sion structures. Argenziano et al. have proposed a 
7-point checklist for dermoscopic scoring in atypical 
melanocytic lesions: atypical pigment network, gray-
blue areas, atypical vascular pattern, radial streaming 
(streaks), irregular diffuse pigmentation (blotches), 
irregular dots and globules, regression pattern (15). 
This approach allows diagnosis of melanoma with a 
sensitivity of 95% and a specificity of 75%. In our cas-
es, all 5 cases studied by dermoscopy showed some 
features of malignancy.
CONCLUSION
Cutaneous melanocytic lesions with atypical his-
tological features can be difficult to categorize as 
benign or malignant, even by experienced patholo-
gists. The MELTUMP category has been widely used in 
the diagnosis of melanocytic lesions, indicating that 
no histological criteria are infallible. This diagnosis is 
provisional and a definitive diagnosis is not always 
possible at initial presentation, and long term clinical 
follow-up remains the only way to understand its bio-
logical behavior. The diagnosis of MELTUMP requires 
expert consultation. In the diagnostic phase, an ac-
curate description of the lesion and the microstaging 
attributes should be reported. Furthermore, the SAM-
PUS and MELTUMP categories should be included in 
the WHO classification of melanocytic tumors of the 
skin. The role of SNL biopsy in MELTUMP remains un-
established. In our experience, the clinical features 
and the dermoscopy were indicative of malignancy. 
In one case a metastatic SLN was found; however, fol-
low-up in all our cases indicates that the clinical out-
come of MELTUMP tends to be favorable.
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